Introduction
Galectin-3, in conjunction with the alpha-3, beta-1 integrin, facilitates cspg4-mediated stimulation of endothelial cell migration. It plays a crucial role in the development of vasculogenic mimicry and angiogenic properties associated with melanoma progression. LGALS3 exhibits high expression levels in the early stages of papillary carcinoma, with a decline in expression intensity as the tumor progresses. Elevated serum levels of LGALS3 are observed in patients with thyroid malignancy, although there is significant overlap in serum LGALS3 concentrations between individuals with benign and malignant nodular thyroid disease. Functioning as an immune regulator, LGLAS3 suppresses T-cell immune responses and promotes tumor growth, thereby providing a novel mechanism for tumor immune tolerance.
Description
Recombinant Human LGALS3, produced in E. coli, is a single, non-glycosylated polypeptide chain consisting of 270 amino acids (1-250 a.a.) with a molecular weight of 28.3 kDa. The protein is fused to a 20 amino acid His-Tag at the N-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
The Galectin-3 protein solution is provided at a concentration of 0.5mg/ml in a buffer consisting of 20mM Tris-HCl (pH 8.0), 0.1M NaCl, 1mM DTT, and 10% Glycerol.
Stability
For short-term storage (up to 2-4 weeks), the product should be stored at 4°C. For longer storage periods, it is recommended to freeze the product at -20°C. To ensure optimal stability during long-term storage, the addition of a carrier protein such as HSA or BSA (0.1%) is advised. Avoid subjecting the product to repeated freeze-thaw cycles.
Purity
The purity of the protein is determined to be greater than 95.0% using SDS-PAGE analysis.
Biological Activity
The biological activity of the protein is assessed by its ability to agglutinate human red blood cells. The ED50 for this effect is determined to be less than 2.5ug/ml.
Synonyms
Galectin-3, GAL3, MAC2, CBP35, GALB, GALIG, LGALS2, LGALS3, Galactose-specific lectin 3, Mac-2 antigen, IgE-binding protein, 35 kDa lectin, Carbohydrate-binding protein 35, CBP 35, Laminin-binding protein, Lectin L-29, L-31, Galactoside-binding protein, GALBP.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MADNFSLHDA LSGSGNPNPQ GWPGAWGNQP AGAGGYPGAS YPGAYPGQAP PGAYPGQAPP GAYPGAPGAY PGAPAPGVYP GPPSGPGAYP SSGQPSATGA YPATGPYGAP AGPLIVPYNL PLPGGVVPRM LITILGTVKP NANRIALDFQ RGNDVAFHFN PRFNENNRRV IVCNTKLDNN WGREERQSVF PFESGKPFKI QVLVEPDHFK VAVNDAHLLQ YNHRVKKLNE ISKLGISGDI DLTSASYTMI.